dc.creatorGrant, Robert M.
dc.creatorLama, Javier R.
dc.creatorAnderson, Peter L.
dc.creatorMcMahan, Vanessa
dc.creatorLiu, Albert Y.
dc.creatorVargas, Lorena
dc.creatorGoicochea, Pedro
dc.creatorCasapía, Martín
dc.creatorGuanira-Carranza, Juan Vicente
dc.creatorRamirez-Cardich, Maria E.
dc.creatorMontoya-Herrera, Orlando
dc.creatorFernández, Telmo
dc.creatorVeloso, Valdiléa G.
dc.creatorBuchbinder, Susan P.
dc.creatorChariyalertsak, Suwat
dc.creatorSchechter, Mauro
dc.creatorBekker, Linda-Gail
dc.creatorMayer, Kenneth H.
dc.creatorKallás, Esper Georges
dc.creatorAmico, K. Rivet
dc.creatorMulligan, Kathleen
dc.creatorBushman, Lane R.
dc.creatorHance, Robert J.
dc.creatorGanoza, Carmela
dc.creatorDefechereux, Patricia
dc.creatorPostle, Brian
dc.creatorWang, Furong
dc.creatorMcConnell, J. Jeff
dc.creatorZheng, Jia-Hua
dc.creatorLee, Jeanny
dc.creatorRooney, James F.
dc.creatorJaffe, Howard S.
dc.creatorMartinez, Ana I.
dc.creatorBurns, David N.
dc.creatorGlidden, David V.
dc.date2018-11-22T17:58:51Z
dc.date2018-11-22T17:58:51Z
dc.date2010
dc.date.accessioned2023-09-26T22:29:19Z
dc.date.available2023-09-26T22:29:19Z
dc.identifierGRANT, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England journal of medicine, v. 363, n. 27, p. 2587-2599, 2010.
dc.identifier0028-4793
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/30170
dc.identifier10.1056/NEJMoa1011205
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8879870
dc.descriptionThe authors’ affiliations are as follows: the Gladstone Institute of Virology and Immunology (R.M.G., V.M., P.G., R.J.H., J.J.M., P.D., J.L.), the University of California, San Francisco (R.M.G., A.Y.L., S.P.B., K.M., F.W., D.V.G.), and the HIV Research Section, San Francisco Department of Public Health (A.Y.L., S.P.B.) — all in San Francisco; Investigaciones Medicas en Salud, Lima (J.R.L., L.V.), Asociación Civil Impacta Salud y Educación, Lima (J.R.L., J.V.G.-C., M.E.R.-C., C.G.), and Asociación Civil Selva Amazónica, Iquitos (M.C.) — all in Peru; the University of Colorado, Denver (P.L.A., L.R.B., J.-H.Z.).; Fundación Ecuatoriana Equidad, Guayaquil, Ecuador (O.M.- H., T.F.); Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Laboratório de Pesquisa Clínica em DST/AIDS (V.G.V.), and Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro (M.S.) — both in Rio de Janeiro; Brown University, Providence, RI (K.H.M.); the Fenway Institute, Fenway Health, Boston (K.H.M.); the Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, and Instituto de Investigação em Imunologia — both in São Paulo (E.G.K.); Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand (S.C.); Desmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town, South Africa (L.-G.B.); Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (A.I.M., D.N.B.); Gilead Sciences, Foster City, CA ( J.F.R., H.S.J.); DF/Net Research, Seattle (B.P.); Applied Health Research, Brighton, MI (K.R.A.); and the Center for Health, Intervention, and Prevention, University of Connecticut, Storrs (K.R.A.).
dc.descriptionAntiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition.
dc.formatapplication/pdf
dc.languageeng
dc.rightsopen access
dc.subjectHIV
dc.subjectDeoxycytidine
dc.subjectEmtricitabine
dc.subjectKaplan-Meier Estimate
dc.subjectOrganophosphonates
dc.subjectPatient Compliance
dc.subjectTenofovir
dc.subjectPreexposure
dc.titlePreexposure chemoprophylaxis for HIV prevention in men who have sex with men
dc.typeArticle


Este ítem pertenece a la siguiente institución